Alimera (ALIM) Rises on Merger Deal With ANI Pharmaceuticals [Yahoo! Finance]
ANI Pharmaceuticals, Inc. (ANIP)
Last ani pharmaceuticals, inc. earnings: 2/27 08:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
anipharmaceuticals.com/investors_corporate_profile.php
Company Research
Source: Yahoo! Finance
ANIP, wherein the latter has agreed to acquire Alimera. Shares of Alimera shot up 75.9% on Jun 24 following the news announcement, while ANIP shares rose 7.3%. Per the deal terms, Alimera is set to be acquired by ANIP for $5.50 per share in cash and its investors will be entitled to a contingent value right for up to $0.50 per share if certain revenue targets are achieved in 2026 and 2027. The purchase price represents a rich premium of 75% on Alimera's closing share price of $3.15 on Jun 21. ANIP will also clear Alimera's debt of $72.5 million. The deal, which values Alimera at almost $381 million in upfront consideration, is expected to close late in the third quarter of 2024, subject to customary closing conditions. The board of directors of ALIM and ANIP have approved the transaction. Shares of Alimera have rallied 28.2% so far this year against the industry's decline of 5.9%. Image Source: Zacks Investment Research Meanwhile, shares of ANI Pharmaceuticals have increas
Show less
Read more
Impact Snapshot
Event Time:
ANIP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ANIP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ANIP alerts
High impacting ANI Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
ANIP
News
- ANI Pharmaceuticals Announces the FDA Approval and Launch of Ketoconazole Shampoo, 2%GlobeNewswire
- ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) had its price target raised by analysts at Raymond James from $81.00 to $83.00. They now have an "outperform" rating on the stock.MarketBeat
- ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $94.00 price target on the stock.MarketBeat
- ANI Pharmaceuticals, Inc. Completes Acquisition of Alimera Sciences [Yahoo! Finance]Yahoo! Finance
- ANI Pharmaceuticals, Inc. Completes Acquisition of Alimera SciencesGlobeNewswire
ANIP
Earnings
- 8/6/24 - Beat
ANIP
Sec Filings
- 9/20/24 - Form 8-K
- 9/16/24 - Form 4
- 9/16/24 - Form 8-K
- ANIP's page on the SEC website